Cardiology - European Medical Journal

Continue

Cardiology

Filter
9 Mins
11 Oct 2021

Ischaemic Cardiomyopathy with Severe Left Ventricular Dysfunction

Cardiomyopathy is a group of diseases that affect the heart muscle. Early on, there may be few or no symptoms. As the disease worsens…
5 Mins
11 Oct 2021

Hydroxychloroquine- and Azithromycin-Induced Transient Left-Bundle Branch Block in a Patient with COVID-19

Since the emergence of the novel coronavirus (referred to as severe acute respiratory syndrome coronavirus 2 [SARS-Cov-2]) in December 2019 in Wuhan City, China, and up until now, several studies and trials have been conducted to manage infected patients…
11 Mins
11 Oct 2021

COVID-19 Infection and Myocardial Infarction Pathophysiology and Therapy

The relationship between COVID-19 and cardiovascular disease has been of interest since the beginning of the pandemic, with the focus more…
EMJ 6.3 2021 Feature Image
9 Mins
21 Sep 2021

Pragmatism and Smoking Cessation: The Role of Harm Reduction in Creating Healthier Smoke-Free Societies

Despite the extensive body of evidence demonstrating the risks of tobacco, many people continue to smoke. Medical science…
EMJ 6.3 2021 Feature Image
9 Mins
21 Sep 2021

Embedding State-of-the-Art of Cardiac Fibrosis Imaging into Standard Practice

The 12-lead ECG has long played the leading role in identifying the region of the heart responsible for tachycardia…
5 Mins
17 Jun 2021

Late-Breaking Abstracts: Health Status Benefits of Mavacamten in Obstructive Hypertrophic Cardiomyopathy and the Modifying Effect of Ejection Fraction on the Therapeutic Benefit of Omecamtiv Mecarbil in Heart Failure

Two late-breaking abstracts at the American College of Cardiology’s virtual meeting ACC.21 delved further into the data of two pivotal trials
8 Mins
17 Jun 2021

Prevalence of Thromboembolic Complications in COVID-19 Infection: A Systematic Review and Meta-Analysis

This study aims to evaluate the prevalence of thromboembolic complications in patients with COVID-19 from March until May 2020.
EMJ Cardiology 9 [Supplement 2] 2021 feature image
12 Mins
25 Mar 2021

Novel Insights into Cardiac Biomarkers in Atrial Fibrillation, Heart Failure, and Coronary Heart Disease | Advancing Understanding and Clinical Application of Cardiac Biomarkers

Oral anticoagulation is currently underused in AF management, with one-third of cases remaining silent and asymptomatic. The STROKESTOP…